Compare PRIM & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRIM | GRFS |
|---|---|---|
| Founded | 1960 | 1940 |
| Country | United States | Spain |
| Employees | 18526 | 25247 |
| Industry | Water Sewer Pipeline Comm & Power Line Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 5.4B |
| IPO Year | 2006 | N/A |
| Metric | PRIM | GRFS |
|---|---|---|
| Price | $103.45 | $7.35 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 2 |
| Target Price | ★ $155.20 | $10.15 |
| AVG Volume (30 Days) | ★ 1.8M | 564.2K |
| Earning Date | 05-05-2026 | 07-28-2022 |
| Dividend Yield | 0.19% | ★ 1.80% |
| EPS Growth | ★ 51.66 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.92 | $4.49 |
| Revenue Next Year | $8.80 | $6.42 |
| P/E Ratio | $383.81 | ★ $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $71.84 | $7.33 |
| 52 Week High | $205.50 | $11.14 |
| Indicator | PRIM | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 35.39 | 35.89 |
| Support Level | $100.83 | N/A |
| Resistance Level | $122.33 | $8.88 |
| Average True Range (ATR) | 8.44 | 0.17 |
| MACD | 0.55 | -0.05 |
| Stochastic Oscillator | 9.42 | 2.21 |
Primoris Services Corp is a provider of critical infrastructure services operating mainly in the United States and Canada. The company provides a range of construction, maintenance, replacement, and engineering services. The Utilities segment operates throughout the United States and specializes in a range of services, including the construction and maintenance of new and existing natural gas and electric utility distribution and transmission systems, and communications systems. The Energy segment operates throughout the United States and Canada and specializes in a range of services that include engineering, procurement, construction, and maintenance services to various industries. The majority of the company's revenue is derived from the Energy segment.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.